Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Herranz

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Haematologica|October 14, 2021
INTERFERing with the progression of T-cell acute lymphoblastic leukemia: a multifaceted therapyDaniel Herranz
Oncotarget|January 6, 2017
Glutaminolysis gets the spotlight in cancerDaniel Herranz
Aging|June 22, 2010
Impact of Sirt1 on mammalian agingDaniel Herranz, Manuel Serrano
Haematologica|January 18, 2024
CApSiZing T-cell acute lymphoblastic leukemiaKomal Mandleywala, Daniel Herranz
Trends in Cancer|November 25, 2018
The MYC Enhancer-ome: Long-Range Transcriptional Regulation of MYC in CancerOlga Lancho, Daniel Herranz
Nature Reviews. Cancer|November 25, 2010
SIRT1: recent lessons from mouse modelsDaniel Herranz, Manuel Serrano
Haematologica|October 24, 2024
Branching NOTCH1 to DNA damage in T-cell acute lymphoblastic leukemiaTanaya Kulkarni, Daniel Herranz
Cell Cycle (Georgetown, Tex.)|January 14, 2015
An oncogenic enhancer enemy (N-Me) in T-ALLDaniel Herranz, Adolfo A Ferrando
Cell Cycle (Georgetown, Tex.)|February 12, 2016
Targeting NOTCH1 in T-ALL: Starving the dragonDaniel Herranz, Adolfo A Ferrando
Blood Cancer Discovery|March 20, 2025
Unleashing the Full Potential of Metabolic Interventions in T-ALLVictoria da Silva-Diz, Daniel Herranz
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Haematologica|October 14, 2021
INTERFERing with the progression of T-cell acute lymphoblastic leukemia: a multifaceted therapyDaniel Herranz
Oncotarget|January 6, 2017
Glutaminolysis gets the spotlight in cancerDaniel Herranz
Aging|June 22, 2010
Impact of Sirt1 on mammalian agingDaniel Herranz, Manuel Serrano
Haematologica|January 18, 2024
CApSiZing T-cell acute lymphoblastic leukemiaKomal Mandleywala, Daniel Herranz
Trends in Cancer|November 25, 2018
The MYC Enhancer-ome: Long-Range Transcriptional Regulation of MYC in CancerOlga Lancho, Daniel Herranz
Nature Reviews. Cancer|November 25, 2010
SIRT1: recent lessons from mouse modelsDaniel Herranz, Manuel Serrano
Haematologica|October 24, 2024
Branching NOTCH1 to DNA damage in T-cell acute lymphoblastic leukemiaTanaya Kulkarni, Daniel Herranz
Cell Cycle (Georgetown, Tex.)|January 14, 2015
An oncogenic enhancer enemy (N-Me) in T-ALLDaniel Herranz, Adolfo A Ferrando
Cell Cycle (Georgetown, Tex.)|February 12, 2016
Targeting NOTCH1 in T-ALL: Starving the dragonDaniel Herranz, Adolfo A Ferrando
Blood Cancer Discovery|March 20, 2025
Unleashing the Full Potential of Metabolic Interventions in T-ALLVictoria da Silva-Diz, Daniel Herranz
Pageof 6